Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Total Liabilities (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Total Liabilities data on record, last reported at $3.7 million in Q3 2025.

  • For Q3 2025, Total Liabilities fell 32.27% year-over-year to $3.7 million; the TTM value through Sep 2025 reached $3.7 million, down 32.27%, while the annual FY2024 figure was $5.1 million, 28.47% down from the prior year.
  • Total Liabilities reached $3.7 million in Q3 2025 per UTMD's latest filing, up from $3.3 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $10.6 million in Q1 2022 and bottomed at $3.3 million in Q2 2025.
  • Average Total Liabilities over 5 years is $7.7 million, with a median of $8.5 million recorded in 2021.
  • Peak YoY movement for Total Liabilities: increased 14.18% in 2021, then plummeted 45.33% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $8.5 million in 2021, then rose by 13.2% to $9.6 million in 2022, then dropped by 25.73% to $7.1 million in 2023, then fell by 28.47% to $5.1 million in 2024, then dropped by 27.16% to $3.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $3.7 million in Q3 2025, $3.3 million in Q2 2025, and $5.5 million in Q1 2025.